Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH 

Madrigal Pharmaceuticals |

Chair: Michael Roden (GER)

13:30 – 13:35IntroductionMichael Roden (GER)
13:35 – 13:50NASH: a growing unmet therapeutic needJörn Schattenberg (GER)
13:50 – 14:05The underestimated role of thyroid hormone pathway in the pathophysiology of NASHEveline Bruinstroop (NLD)
14:05 – 14:20Discussion and Q&AsMichael Roden (GER)
Jörn Schattenberg (GER)
Eveline Bruinstroop (NLD)
14:20 – 14:30Key take home messages and close Michael Roden (GER)